Redona Therapeutics

Cambridge, United States · $80.0M raised

Employees
1–10
Business Model
B2B
Total Funding
$80.0M
Last Round
$15.0M Series AMay 2019
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Redona Therapeutics is a clinical-stage biopharmaceutical company focused on discovering novel therapeutics that target enzymes contributing to the dysregulation of RNA and DNA processes in serious diseases, including cancer and autoimmune conditions. The company was co-founded by Harvard Medical School professors alongside experienced biopharma executives, with scientific founders from HMS's Initiative for RNA Medicine and the Institute of RNA Medicine at Beth Israel Deaconess Medical Center. Redona's pipeline is grounded in the understanding that dysregulation of RNA and DNA processing mechanisms underlies multiple serious diseases. The leadership team brings decades of drug discovery experience from institutions including Epizyme, IFM Therapeutics, Biogen, and MPM Capital.

Summary

Redona Therapeutics is a Biotech company based in Cambridge, United States. It has raised $80.0M in total across 2 rounds, most recently a $15.0M Series A round in May 2019. Investors include Sofinnova Partners, Astellas Venture Management and Osage University Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2019
$15.0M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Redona Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/redona-therapeutics"><img src="https://indexed.vc/api/badge/company/redona-therapeutics" alt="Redona Therapeutics on Indexed.vc" width="260" height="76" /></a>